S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
S&P 500   3,633.64 (+1.57%)
DOW   30,031.24 (+1.49%)
QQQ   294.72 (+1.49%)
AAPL   115.60 (+1.54%)
MSFT   213.26 (+1.50%)
FB   277.39 (+3.34%)
GOOGL   1,762.03 (+2.00%)
AMZN   3,120.03 (+0.70%)
TSLA   557.04 (+6.74%)
NVDA   518.38 (-1.37%)
BABA   279.71 (+3.55%)
CGC   26.98 (+9.14%)
GE   10.47 (+3.97%)
MU   63.72 (-0.72%)
AMD   85.06 (-0.29%)
T   29.22 (+2.10%)
NIO   53.58 (-3.25%)
F   9.42 (+6.32%)
ACB   9.12 (+27.02%)
NFLX   483.73 (+1.49%)
GILD   60.47 (+0.97%)
BA   218.98 (+3.52%)
DIS   151.68 (+3.90%)
Log in
NASDAQ:CLVS

Clovis Oncology News Headlines

$4.37
+0.19 (+4.55 %)
(As of 11/24/2020 03:27 PM ET)
Add
Compare
Today's Range
$4.13
Now: $4.37
$4.49
50-Day Range
$4.13
MA: $5.11
$6.41
52-Week Range
$3.62
Now: $4.37
$17.37
Volume238,270 shs
Average Volume6.08 million shs
Market Capitalization$385.95 million
P/E RatioN/A
Dividend YieldN/A
Beta2.37

Headlines

Clovis Oncology (NASDAQ CLVS) News Headlines Today

Source:
SourceHeadline
Clovis Oncology (NASDAQ:CLVS) Raised to "Buy" at ValuEngineClovis Oncology (NASDAQ:CLVS) Raised to "Buy" at ValuEngine
marketbeat.com - November 10 at 1:10 AM
BidaskClub Lowers Clovis Oncology (NASDAQ:CLVS) to Strong SellBidaskClub Lowers Clovis Oncology (NASDAQ:CLVS) to Strong Sell
marketbeat.com - October 28 at 3:07 AM
Clovis Oncology (NASDAQ:CLVS) Rating Reiterated by HC WainwrightClovis Oncology (NASDAQ:CLVS) Rating Reiterated by HC Wainwright
marketbeat.com - September 21 at 7:42 AM
Clovis Oncology (NASDAQ:CLVS) Cut to "Strong Sell" at BidaskClubClovis Oncology (NASDAQ:CLVS) Cut to "Strong Sell" at BidaskClub
marketbeat.com - August 13 at 3:13 AM
Clovis Oncology to Present at the Piper Sandler 32nd Annual Healthcare ConferenceClovis Oncology to Present at the Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 20 at 12:47 PM
Clovis Oncology: Cash Position Is Tight, We Question Managements GuidanceClovis Oncology: Cash Position Is Tight, We Question Management's Guidance
seekingalpha.com - November 9 at 6:29 PM
Clovis Oncology, Inc. (NASDAQ:CLVS) Just Reported And Analysts Have Been Cutting Their EstimatesClovis Oncology, Inc. (NASDAQ:CLVS) Just Reported And Analysts Have Been Cutting Their Estimates
nasdaq.com - November 8 at 12:52 PM
Clovis Oncology, Inc. (NASDAQ:CLVS) Analysts Are Cutting Their Estimates: Heres What You Need To KnowClovis Oncology, Inc. (NASDAQ:CLVS) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 8 at 12:52 PM
Clovis Oncology (NASDAQ:CLVS) Releases  Earnings Results, Beats Estimates By $0.12 EPSClovis Oncology (NASDAQ:CLVS) Releases Earnings Results, Beats Estimates By $0.12 EPS
americanbankingnews.com - November 6 at 11:14 PM
Clovis Oncology: Reloading Before And After Q3 Earnings For The Long TermClovis Oncology: Reloading Before And After Q3 Earnings For The Long Term
seekingalpha.com - November 6 at 6:18 PM
Clovis (CLVS) Q3 Earnings Top, Sales Show Coronavirus ImpactClovis (CLVS) Q3 Earnings Top, Sales Show Coronavirus Impact
finance.yahoo.com - November 6 at 1:17 PM
SVB Leerink Cuts Clovis Oncology (NASDAQ:CLVS) Price Target to $3.00SVB Leerink Cuts Clovis Oncology (NASDAQ:CLVS) Price Target to $3.00
americanbankingnews.com - November 6 at 12:31 PM
HC Wainwright Trims Clovis Oncology (NASDAQ:CLVS) Target Price to $15.00HC Wainwright Trims Clovis Oncology (NASDAQ:CLVS) Target Price to $15.00
americanbankingnews.com - November 6 at 10:06 AM
Clovis Oncology (NASDAQ:CLVS) Trading Down 21.2% Following Analyst DowngradeClovis Oncology (NASDAQ:CLVS) Trading Down 21.2% Following Analyst Downgrade
americanbankingnews.com - November 5 at 10:14 PM
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q3 2020 Results - Earnings Call TranscriptClovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 10:05 PM
Clovis down 21% on job cuts, convertible debt offeringClovis down 21% on job cuts, convertible debt offering
seekingalpha.com - November 5 at 5:04 PM
Clovis Oncology (NASDAQ:CLVS) Receives Neutral Rating from Piper SandlerClovis Oncology (NASDAQ:CLVS) Receives Neutral Rating from Piper Sandler
americanbankingnews.com - November 5 at 1:33 PM
Clovis Oncology EPS beats by $0.11, misses on revenueClovis Oncology EPS beats by $0.11, misses on revenue
seekingalpha.com - November 5 at 12:04 PM
Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue EstimatesClovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 5 at 12:03 PM
Clovis Oncology (NASDAQ:CLVS) Trading 5.3% Higher Clovis Oncology (NASDAQ:CLVS) Trading 5.3% Higher
americanbankingnews.com - November 3 at 8:38 PM
Clovis Oncologys (CLVS) Hold Rating Reiterated at JPMorgan Chase & Co.Clovis Oncology's (CLVS) Hold Rating Reiterated at JPMorgan Chase & Co.
americanbankingnews.com - November 1 at 7:29 AM
Clovis Oncology to Announce Third Quarter 2020 Financial Results and Host Webcast Conference Call on November 5Clovis Oncology to Announce Third Quarter 2020 Financial Results and Host Webcast Conference Call on November 5
finance.yahoo.com - October 20 at 5:51 PM
Global Brain Tumor Therapeutics Market Projected to Exceed $2.70 Billion By 2023Global Brain Tumor Therapeutics Market Projected to Exceed $2.70 Billion By 2023
finanznachrichten.de - October 1 at 2:01 PM
Clovis Oncology Stock Tanked 14% Yesterday: Time To Buy?Clovis Oncology Stock Tanked 14% Yesterday: Time To Buy?
nasdaq.com - September 28 at 8:58 AM
Clovis Oncology Stock Down 18% This Week: Time To Buy?Clovis Oncology Stock Down 18% This Week: Time To Buy?
forbes.com - September 25 at 9:44 AM
EU agency recommends AstraZeneca-Merck drug Lynparza for two cancersEU agency recommends AstraZeneca-Merck drug Lynparza for two cancers
reuters.com - September 21 at 7:57 AM
New Data Presented at ESMO Virtual Congress 2020 Highlight Breadth and Potential of Clovis Oncology Products and PipelineNew Data Presented at ESMO Virtual Congress 2020 Highlight Breadth and Potential of Clovis Oncology Products and Pipeline
finance.yahoo.com - September 17 at 3:44 AM
Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global MeetingClovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting
finance.yahoo.com - September 10 at 12:50 PM
Five Pharmaceutical Stocks Investors May Want to Keep an Eye OnFive Pharmaceutical Stocks Investors May Want to Keep an Eye On
baystreet.ca - September 9 at 8:41 AM
Clovis Oncology to Highlight Data for its Three Portfolio Compounds at the ESMO Virtual Congress 2020Clovis Oncology to Highlight Data for its Three Portfolio Compounds at the ESMO Virtual Congress 2020
businesswire.com - September 9 at 8:16 AM
Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceClovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 5:40 PM
Clovis (CLVS) Down 17.3% Since Last Earnings Report: Can It Rebound?Clovis (CLVS) Down 17.3% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 5 at 2:28 PM
The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbotts $5, 15-Minute COVID-19 TestThe Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test
msn.com - August 27 at 10:23 AM
ROCE Insights For Clovis OncologyROCE Insights For Clovis Oncology
benzinga.com - August 27 at 10:23 AM
FDA OKs FoundationOne CDx as a companion Dx for Clovis Oncologys rucaparibFDA OKs FoundationOne CDx as a companion Dx for Clovis Oncology's rucaparib
seekingalpha.com - August 27 at 4:16 AM
Return On Capital Employed Overview: Clovis OncologyReturn On Capital Employed Overview: Clovis Oncology
finance.yahoo.com - August 18 at 2:30 PM
Thinking about buying stock in NovaBay Pharmaceuticals, RISE Education, eMagin Corp, Avinger Inc, or Clovis Oncology?Thinking about buying stock in NovaBay Pharmaceuticals, RISE Education, eMagin Corp, Avinger Inc, or Clovis Oncology?
prnewswire.com - August 18 at 9:51 AM
Clovis up 20% on rucaparib data in prostate cancerClovis up 20% on rucaparib data in prostate cancer
seekingalpha.com - August 17 at 7:19 PM
Why Clovis Oncology's Stock Is Trading Higher TodayWhy Clovis Oncology's Stock Is Trading Higher Today
finance.yahoo.com - August 17 at 7:19 PM
Why Clovis Oncologys Stock Is Trading Higher TodayWhy Clovis Oncology's Stock Is Trading Higher Today
benzinga.com - August 17 at 3:28 PM
First Week of CLVS September 18th Options TradingFirst Week of CLVS September 18th Options Trading
nasdaq.com - August 17 at 2:14 PM
Journal of Clinical Oncology Publishes Additional Data from Clovis Oncology’s TRITON2 Clinical Trial Evaluating Rubraca® (rucaparib) for the Treatment of mCRPC in Patients with BRCA1/2 Gene MutationsJournal of Clinical Oncology Publishes Additional Data from Clovis Oncology’s TRITON2 Clinical Trial Evaluating Rubraca® (rucaparib) for the Treatment of mCRPC in Patients with BRCA1/2 Gene Mutations
businesswire.com - August 17 at 8:26 AM
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q2 2020 Results - Earnings Call TranscriptClovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 2:15 AM
Clovis: 2Q Earnings SnapshotClovis: 2Q Earnings Snapshot
finance.yahoo.com - August 6 at 9:15 PM
Clovis Oncology (CLVS) Reports Q2 Loss, Misses Revenue EstimatesClovis Oncology (CLVS) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 6 at 9:15 PM
Clovis launches mid-stage study of lucitanib in gynecologic cancersClovis launches mid-stage study of lucitanib in gynecologic cancers
seekingalpha.com - August 5 at 9:46 AM
Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic CancersClovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers
finance.yahoo.com - August 5 at 9:46 AM
Clovis Oncology (CLVS) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseClovis Oncology (CLVS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.nasdaq.com - July 30 at 3:31 PM
Clovis Oncology (CLVS) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseClovis Oncology (CLVS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - July 30 at 3:31 PM
Clovis Oncology to Announce Second Quarter 2020 Financial Results and Host Webcast Conference Call on August 6Clovis Oncology to Announce Second Quarter 2020 Financial Results and Host Webcast Conference Call on August 6
finance.yahoo.com - July 23 at 1:41 PM
Hedge Funds Never Been Less Bullish On Clovis Oncology Inc (CLVS)Hedge Funds Never Been Less Bullish On Clovis Oncology Inc (CLVS)
finance.yahoo.com - June 30 at 7:15 PM
Clovis Oncology to Highlight Rubraca® (rucaparib) and Lucitanib Non-Clinical Data at the AACR Virtual Annual Meeting II 2020Clovis Oncology to Highlight Rubraca® (rucaparib) and Lucitanib Non-Clinical Data at the AACR Virtual Annual Meeting II 2020
finance.yahoo.com - June 17 at 8:19 AM
Clovis Completes Enrollment in Late-Stage Ovarian Cancer StudyClovis Completes Enrollment in Late-Stage Ovarian Cancer Study
finance.yahoo.com - June 11 at 2:53 PM
Clovis completes enrollment in study of Rubraca combo in ovarian cancerClovis completes enrollment in study of Rubraca combo in ovarian cancer
seekingalpha.com - June 10 at 5:25 PM
This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.